+61 3 7038 0982 102 Fox Drive Dandenong South VIC 3175

Investor Prospectus


By accessing the electronic Prospectus, you agree to and acknowledge reading these terms. If you would like us to send you a copy of the Prospectus and an Application Form, please contact the information line by telephone on 1300 737 760 (within Australia) or +61 2 92909600 (outside Australia) during the period in which the offer for shares remains open and a copy will be sent to you free of charge.

1. Prospectus

Eagle Health Holdings Limited (ACN 616 382515) (Company) lodged a Second Replacement Prospectus dated 24 April 2017 (Prospectus) with the Australian Securities and Investments Commission (ASIC) to raise up to $30 million by issuing up to 75 million fully paid ordinary shares (Shares) at $0.40 per share (Offer). The Offer will only be made pursuant to the Prospectus and full details of the Offer are set out in the Prospectus.

No person is authorised to give any information or to make any representation in relation to the Offer which is not contained in the Prospectus and any such information may not be relied upon ashaving been authorised by the Company.

2. Important information

This notice does not form part of the Prospectus. You must read it before you attempt to access the electronic version of the Prospectus on this website and indicate your agreement orotherwise at the bottom of this notice.

The Prospectus is an important document that should be read in its entirety. Potential investors should read the entire Prospectus and, in particular, in considering the prospects for the Company, investors should consider the risk factors that could affect the performance of the Company.

Investors should carefully consider these factors in light of their personal circumstances (including financial and taxation issues) and seek professional advice from a licensed investment adviser. The Prospectus expireson 23 May 2018. No Shares will be issued on the basis of the Prospectus afterthat expiry date.

3. Foreign Jurisdictions

This Prospectus does not, and is not intended to, constitute an offer in any place or jurisdiction in which, or to any person to whom, it would not be lawful to make such an offer or to issue the Prospectus. The distribution of the Prospectus in jurisdictions outside Australia may be restricted by law and persons who come into possession of the Prospectus should seek advice on and observe any such restrictions including government or other consents and formalities. Any failure to comply with such restrictions may constitute a violation of applicable securities laws. It is the responsibility of any applicant outside Australia to ensure compliance with all laws of any country relevant to their application.

No action has been taken to register orqualify the Shares, or otherwise to permit a public offering of the Shares, in any jurisdiction outside Australia and the Offer is not an offer or invitation in any jurisdiction where, or to any person whom, such an offer or invitation would be unlawful. In particular, the Shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended (US Securities Act) and may not be offered or sold in the United States except intransaction exempt from, or not subject to, registration under the USSecurities Act and applicable US state securities laws.

By proceeding, you confirm that you are aresident of Australia accessing this website from within Australia and you’re present, warrant and agree that you are not in the United States or any other jurisdiction outside Australia.

4. Application for Shares

After the expiry of the Exposure Period, the electronic version of the Prospectus will include an Application Form atthe end of the document. Applications for Shares may only be made by completing and lodging the Application Form attached to or accompanied by a paper copy of the Prospectus in accordance with the directions specified in the Prospectus.

The Corporations Act prohibits any person from distributing to any other person an Application Form unless it is attached to a paper copy of the Prospectus or accompanies a complete and unaltered version of the electronic Prospectus. The Company will not accept a completed Application Form if it has reason to believe that the applicant hasnot received a complete and unaltered copy of the Prospectus. Any person may obtain a paper copy of the Prospectus by contacting the Company prior to the Closing Date for the Offer.

5. Acknowledgement

The information on this website is provided for informational purposes only and subject to change without notice. Nothing contained on this website or in the Prospectus constitutes investment, legal, business, taxation or other advice, nor is it to be relied on in making an investment in the Shares. The information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs. If you have any doubts or queries in relation to the Prospectus, you should consult your legal, financial or other professional adviser.

Subject to the terms contained in this notice, an electronic copy of the Prospectus may be viewed or downloaded. You should ensure that any copy you view or print is complete.

No previous No next

Contact us


Eagle Health Holdings Limited

Phone:+61 3 7038 0982

Email: jonathanpe@msn.com

Address:102 Fox Drive Dandenong South VIC 3175